First-line Therapy in Metastatic PDAC

NCT03487016 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

270

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Pancreatic Cancer

Interventions

DRUG: Gemcitabine
DRUG: Nab-paclitaxel
DRUG: 5-FU
DRUG: Irinotecan Liposomal Injection
DRUG: Oxaliplatin

Sponsor

Ludwig-Maximilians - University of Munich